Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: Low yield and absence of clinical consequences

American Journal of Gastroenterology

Volumn 109, Issue 5, 2014, Pages 715-722

  Van Den Broek, Frank J C ^a   Stokkers, Pieter C F ^a   Reitsma, Johannes B ^a   Boltjes, Robin P B ^a   Ponsioen, Cyriel Y ^a   Fockens, Paul ^a   Dekker, Evelien ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHILD; COLONOSCOPY; DISEASE SURVEILLANCE; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; HIGH GRADE INTRAEPITHELIAL NEOPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW GRADE INTRAEPITHELIAL NEOPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RANDOM BIOPSY; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TUMOR DIAGNOSIS; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA IN SITU; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84899973580     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.93     Document Type: Article

References (17)

1. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51 (Suppl 5): V10-2.
2. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 314-21.
3. Rubin CE, Haggitt RC, Burmer GC et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103: 1611-20.
4. Rubin DT, Rothe JA, Hetzel JT et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 2007; 65: 998-1004.
5. Blonski W, Kundu R, Lewis J et al. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis? Scand J Gastroenterol 2008; 43: 698-703.
6. Rutter MD, Saunders BP, Wilkinson KH et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004; 60: 334-9.
7. Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-8.
8. Rutter MD, Saunders BP, Schofield G et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-60.
9. Hurlstone DP, Sanders DS, Lobo AJ et al. Indigo carmine-assisted highmagnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005; 37: 1186-92.
10. Kiesslich R, Goetz M, Lammersdorff K et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007; 132: 874-82.
11. Marion JF, Waye JD, Present DH et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008; 103: 2342-9.
12. van den Broek FJ, Fockens P, van den S et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomized comparison of high resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow band imaging for classification of lesions. Gut 2008; 57: 1083-9.
13. Rutter MD, Saunders BP, Wilkinson KH et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004; 53: 1813-6.
14. Satsangi J, Silverberg MS, Vermeire S et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
15. Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
16. Marion JF. An expensive and empty ritual: the continued use of random biopsy technique for detecting dysplasia in patients with colitis-pro. Inflamm Bowel Dis 2007; 13: 1271-2.
17. Rutter M, Saunders B, Wilkinson K et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-9.